about
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas.Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cellsApoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.Molecular and genetic pathways in gliomas: the future of personalized therapeutics.Small-animal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury.Irradiation facilitates the inhibitory effect of the heat shock protein 90 inhibitor NVP-BEP800 on the proliferation of malignant glioblastoma cells through attenuation of the upregulation of heat shock protein 70.Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy.Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
P2860
Q34886836-47F6A8D4-F0A2-470C-A602-1B0A1A285121Q35793074-014E4AC4-9C64-4A57-93C6-B1A10DA470E6Q37695245-91516F7D-FBA9-42CD-9A81-6CFB3C9ED0AAQ37718142-EFE3C855-B33F-46C3-A004-D249750EF6D9Q38233171-2260490B-6C1C-4FB6-A255-FB82AC4028B0Q41458017-94BB0086-9D41-48B5-BFED-4E13B94900F6Q41827236-33BCE6C7-1433-444F-BCEB-DD61C5B536EFQ47104354-E9546619-C435-4993-AA27-A4F403705E5CQ48235199-82B59932-46D1-4EEB-B995-795046577F6AQ52148215-7F603B33-C054-4F71-842D-AEF9D62DFC59
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bevacizumab for the treatment of glioblastoma.
@en
type
label
Bevacizumab for the treatment of glioblastoma.
@en
prefLabel
Bevacizumab for the treatment of glioblastoma.
@en
P2860
P1476
Bevacizumab for the treatment of glioblastoma.
@en
P2093
Marc Chamberlain
Sajeel Chowdhary
P2860
P304
P356
10.1586/14737175.2013.827414
P577
2013-08-16T00:00:00Z